1. |
Yamaguchi A, Goi T, Yu J, et al. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and longterm prognosis [J]. J Surg Oncol, 2002; 79(4)∶230.
|
2. |
Xin Y, Grace A, Gallagher MM, et al. CD44V6 in gastric carcinoma: a marker of tumor progression [J]. Appl Immunohistochem Mol Morphol, 2001; 9(2)∶138.
|
3. |
Stachura J, Krzeszowiak A, Popiela T, et al. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades Ⅰ and Ⅲ [J]. Pol J Pathol, 1999; 50(3)∶155.
|
4. |
Van Driel M, Gunthert U, van Kessel AC, et al. CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells [J]. Leukemia, 2002; 16(1)∶135.
|
5. |
Gulmann C, Grace A, Leader M, et al. CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays [J]. Eur J Gastroenterol Hepatol, 2003; 15(9)∶981.
|
6. |
Joo M, Lee HK, Kang YK. Expression of Ecadherin, betacatenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis [J]. Anticancer Res, 2003; 23(2B)∶1581.
|
7. |
Koyama S, Maruyama T, Adachi S. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a twocolor flowcytometric analysis [J]. J Cancer Res Clin Oncol, 1999; 125(1)∶47.
|
8. |
Nakashio T, Narita T, Sato M, et al. The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer [J]. Anticancer Res, 1997; (1A)∶293.
|